WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”) today responded to the latest element of the low-road campaign that Ziopharm Oncology, Inc. (NASDAQ: ZIOP)
(“Ziopharm” or the “Company”) is waging in response to our consent solicitation.

Robert Postma, principal and founder of WaterMill, commented:

“This latest chapter of Ziopharm’s low-road